Robert A. Minow

872 total citations
11 papers, 712 citations indexed

About

Robert A. Minow is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Neurology. According to data from OpenAlex, Robert A. Minow has authored 11 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 2 papers in Infectious Diseases and 2 papers in Neurology. Recurrent topics in Robert A. Minow's work include Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cardiac pacing and defibrillation studies (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Robert A. Minow is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cardiac pacing and defibrillation studies (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Robert A. Minow collaborates with scholars based in United States. Robert A. Minow's co-authors include Jeffrey A. Gottlieb, Robert S. Benjamin, Elisa T. Lee, Samuel I. Rapaport, Ariella Zivelin, Mario A. Luna, Victorio Rodriguez, John H. Casey, Emil J. Freireich and Ronald K. Tompkins and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Clinical Pharmacology & Therapeutics.

In The Last Decade

Robert A. Minow

11 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Minow United States 8 401 266 110 105 86 11 712
Peter Stecy United States 6 499 1.2× 154 0.6× 35 0.3× 182 1.7× 46 0.5× 9 658
Harry Gibbs Australia 11 699 1.7× 386 1.5× 56 0.5× 178 1.7× 117 1.4× 37 1.2k
James C. Wernz United States 9 232 0.6× 370 1.4× 37 0.3× 44 0.4× 59 0.7× 11 561
Gülten Tekuzman Türkiye 15 234 0.6× 334 1.3× 70 0.6× 55 0.5× 111 1.3× 58 737
Joseph Swafford United States 13 856 2.1× 460 1.7× 54 0.5× 182 1.7× 130 1.5× 28 1.2k
Alessandro Martinoni Italy 10 895 2.2× 380 1.4× 29 0.3× 55 0.5× 40 0.5× 12 993
Elly Barry United States 12 519 1.3× 310 1.2× 308 2.8× 48 0.5× 157 1.8× 24 1.2k
Ladislav Jebavý Czechia 14 223 0.6× 199 0.7× 130 1.2× 31 0.3× 69 0.8× 52 517
D Venzon United States 7 149 0.4× 325 1.2× 53 0.5× 56 0.5× 82 1.0× 7 725
Mustafa Dikilitaş Türkiye 12 221 0.6× 327 1.2× 22 0.2× 42 0.4× 107 1.2× 39 600

Countries citing papers authored by Robert A. Minow

Since Specialization
Citations

This map shows the geographic impact of Robert A. Minow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Minow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Minow more than expected).

Fields of papers citing papers by Robert A. Minow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Minow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Minow. The network helps show where Robert A. Minow may publish in the future.

Co-authorship network of co-authors of Robert A. Minow

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Minow. A scholar is included among the top collaborators of Robert A. Minow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Minow. Robert A. Minow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rapaport, Samuel I., et al.. (1992). Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin. American Journal of Clinical Pathology. 97(1). 84–91. 105 indexed citations
2.
Minow, Robert A., et al.. (1978). QRS voltage change with adriamycin administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(6). 931–4. 30 indexed citations
3.
Minow, Robert A., Robert S. Benjamin, Elisa T. Lee, & Jeffrey A. Gottlieb. (1977). Adriamycin cardiomyopathy—risk factors. Cancer. 39(4). 1397–1402. 212 indexed citations
4.
Minow, Robert A., et al.. (1976). Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and adriamycin. Cancer. 38(4). 1524–1528. 43 indexed citations
5.
Minow, Robert A., Jeffrey A. Gottlieb, & Emil J. Freireich. (1975). Electrocardiogram QRS voltage changes in adriamycin cardiomyopathy. Proceedings of the American Association for Cancer Research. 16(66). 5 indexed citations
6.
Minow, Robert A., Robert S. Benjamin, & Jeffrey A. Gottlieb. (1975). Concurrent cyclophosphamide (CTX), mediastinal radiotherapy (MXRT), and other factors increasing the risk of adriamycin (A) induced cardiomyopathy (CMY). Clinical research. 23(3). 1 indexed citations
7.
Minow, Robert A.. (1975). Adriamycin Cardiotoxicity. Annals of Internal Medicine. 82(6). 855–855. 13 indexed citations
8.
Minow, Robert A., Ronald K. Tompkins, & Gary Gitnick. (1975). Diarrhea syndrome in hepatic adenoma. Digestive Diseases and Sciences. 20(2). 182–186. 5 indexed citations
9.
Minow, Robert A., Robert S. Benjamin, & Jeffrey A. Gottlieb. (1975). Adriamycin (NSC 123127) cardiomyopathy. An overview with determination of risk factors. 6(2). 195–201. 225 indexed citations
10.
Rodriguez, Victorio, Gerald P. Bodey, Kenneth B. McCredie, et al.. (1975). Combination 6‐mercaptopurine‐adriamycin in refractory adult acute leukemia. Clinical Pharmacology & Therapeutics. 18(4). 462–466. 14 indexed citations
11.
Minow, Robert A., et al.. (1974). Myoglobinuria Associated with Influenza A Infection. Annals of Internal Medicine. 80(3). 359–361. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026